Dr. Jeffrey R. Jay, M.D. as of Dec. 31, 2012
Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D. holds 25 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Furiex Pharmaceuticals | 11.3 | $12M | 632k | 19.26 | |
| ACADIA Pharmaceuticals (ACAD) | 10.2 | $11M | 2.4M | 4.65 | |
| OncoGenex Pharmaceuticals | 10.1 | $11M | 823k | 13.12 | |
| Hyperion Therapeutics | 8.1 | $8.7M | 772k | 11.28 | |
| Vanda Pharmaceuticals (VNDA) | 7.9 | $8.5M | 2.3M | 3.70 | |
| Questcor Pharmaceuticals | 7.5 | $8.0M | 300k | 26.72 | |
| Celsion Corporation | 6.4 | $6.9M | 844k | 8.19 | |
| Acelrx Pharmaceuticals | 6.0 | $6.5M | 1.5M | 4.26 | |
| Amarin Corporation (AMRN) | 4.8 | $5.1M | 633k | 8.09 | |
| EXACT Sciences Corporation (EXAS) | 4.1 | $4.4M | 415k | 10.59 | |
| Pain Therapeutics | 3.5 | $3.7M | 1.4M | 2.71 | |
| D Horizon Pharma | 3.2 | $3.4M | 1.5M | 2.33 | |
| Biodel | 3.0 | $3.2M | 1.4M | 2.35 | |
| Vascular Solutions | 2.9 | $3.2M | 200k | 15.80 | |
| RTI Biologics | 2.0 | $2.1M | 500k | 4.27 | |
| Affymax (AFFY) | 1.6 | $1.7M | 89k | 18.99 | |
| Accuray Incorporated (ARAY) | 1.5 | $1.6M | 250k | 6.43 | |
| Palatin Technologies | 1.5 | $1.6M | 2.6M | 0.60 | |
| Zogenix | 1.4 | $1.5M | 1.1M | 1.33 | |
| Targacept | 1.0 | $1.1M | 244k | 4.38 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $828k | 32k | 25.81 | |
| NPS Pharmaceuticals | 0.6 | $687k | 76k | 9.10 | |
| Oncothyreon | 0.6 | $683k | 356k | 1.92 | |
| Mei Pharma | 0.1 | $155k | 1.1M | 0.14 | |
| AMAG Pharmaceuticals | 0.0 | $2.0k | 150.00 | 13.33 |
